Biotechs Should Bring Their A-Game To Their Name
San Francisco Business Times -- It’s a bad time for A-list biotech companies. From Anesiva to Avigen, a number of biotech companies with names starting with an “a” and including a “v” are facing tough times. So is it the name — or the companies — that are not so sweet?